Picture loading failed.

Anti-EPCAM therapeutic antibody (Pre-made Citatuzumab biosimilar,Fab Fusion) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-107-1mg 1mg 3090
GMP-Bios-ab-107-10mg 10mg 21890
GMP-Bios-ab-107-100mg 100mg 148000
GMP-Bios-ab-107-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-EPCAM therapeutic antibody (Pre-made Citatuzumab biosimilar,Fab Fusion)
INN Name Citatuzumab
TargetEPCAM
FormatFab Fusion
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2008
Year Recommended2009
CompaniesViventia Biotech;Sesen Bio
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedSolid tumours
Development Techna